These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 21978631

  • 1. Hormone therapy and coronary heart disease risk by vasomotor menopausal symptoms.
    Gast GC, Pop VJ, Samsioe GN, Grobbee DE, Nilsson PM, Keyzer JJ, Wijnands-van Gent CJ, van der Schouw YT.
    Maturitas; 2011 Dec; 70(4):373-8. PubMed ID: 21978631
    [Abstract] [Full Text] [Related]

  • 2. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
    Blümel JE, Chedraui P, Baron G, Belzares E, Bencosme A, Calle A, Danckers L, Espinoza MT, Flores D, Gomez G, Hernandez-Bueno JA, Izaguirre H, Leon-Leon P, Lima S, Mezones-Holguin E, Monterrosa A, Mostajo D, Navarro D, Ojeda E, Onatra W, Royer M, Soto E, Tserotas K, Vallejo S, Collaborative Group for Research of the Climacteric in Latin America (REDLINC).
    Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
    [Abstract] [Full Text] [Related]

  • 3. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
    Svartberg J, von Mühlen D, Kritz-Silverstein D, Barrett-Connor E.
    Menopause; 2009 Jul; 16(5):888-91. PubMed ID: 19421076
    [Abstract] [Full Text] [Related]

  • 4. Hot flushes and night sweats are associated with coronary heart disease risk in midlife: a longitudinal study.
    Herber-Gast G, Brown WJ, Mishra GD.
    BJOG; 2015 Oct; 122(11):1560-7. PubMed ID: 25377022
    [Abstract] [Full Text] [Related]

  • 5. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F, Manson JE, Stampfer MJ.
    J Womens Health (Larchmt); 2006 Oct; 15(1):35-44. PubMed ID: 16417416
    [Abstract] [Full Text] [Related]

  • 6. Vasomotor symptoms and cardiovascular disease risk.
    Pines A.
    Climacteric; 2011 Oct; 14(5):535-6. PubMed ID: 21848496
    [Abstract] [Full Text] [Related]

  • 7. Vasomotor menopausal symptoms are not associated with incidence of breast cancer in a population-based cohort of mid-aged women.
    Johanneke van den Berg M, Mishra GD, van der Schouw YT, Herber-Gast GC.
    Eur J Cancer; 2014 Mar; 50(4):824-30. PubMed ID: 24361228
    [Abstract] [Full Text] [Related]

  • 8. Hot flushes and night sweats differ in associations with cardiovascular markers in healthy early postmenopausal women.
    Hitchcock CL, Elliott TG, Norman EG, Stajic V, Teede H, Prior JC.
    Menopause; 2012 Nov; 19(11):1208-14. PubMed ID: 22781788
    [Abstract] [Full Text] [Related]

  • 9. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E, Zyriax BC, Eidenmüller B, Boeing H.
    Maturitas; 2007 Jul 20; 57(3):239-46. PubMed ID: 17292571
    [Abstract] [Full Text] [Related]

  • 10. Hormone therapy for the management of menopausal symptoms: pharmacotherapy update.
    Woodis CB.
    J Pharm Pract; 2010 Dec 20; 23(6):540-7. PubMed ID: 21507860
    [Abstract] [Full Text] [Related]

  • 11. Vasomotor symptoms are associated with a lower bone mineral density.
    Gast GC, Grobbee DE, Pop VJ, Keyzer JJ, Wijnands-van Gent CJ, Samsioe GN, Nilsson PM, van der Schouw YT.
    Menopause; 2009 Dec 20; 16(2):231-8. PubMed ID: 19034053
    [Abstract] [Full Text] [Related]

  • 12. Vasomotor and sexual symptoms in older Australian women: a cross-sectional study.
    Zeleke BM, Bell RJ, Billah B, Davis SR.
    Fertil Steril; 2016 Jan 20; 105(1):149-55.e1. PubMed ID: 26450529
    [Abstract] [Full Text] [Related]

  • 13. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women.
    Albert CM, Chae CU, Rexrode KM, Manson JE, Kawachi I.
    Circulation; 2005 Feb 01; 111(4):480-7. PubMed ID: 15687137
    [Abstract] [Full Text] [Related]

  • 14. Vasomotor symptoms and risk of cardiovascular disease in peri- and postmenopausal women: A systematic review and meta-analysis.
    Armeni A, Anagnostis P, Armeni E, Mili N, Goulis D, Lambrinoudaki I.
    Maturitas; 2023 May 01; 171():13-20. PubMed ID: 36907116
    [Abstract] [Full Text] [Related]

  • 15. Type of menopause, patterns of hormone therapy use, and hot flashes.
    Gallicchio L, Whiteman MK, Tomic D, Miller KP, Langenberg P, Flaws JA.
    Fertil Steril; 2006 May 01; 85(5):1432-40. PubMed ID: 16566933
    [Abstract] [Full Text] [Related]

  • 16. Dietary factors and vasomotor symptoms in breast cancer survivors: the WHEL Study.
    Gold EB, Flatt SW, Pierce JP, Bardwell WA, Hajek RA, Newman VA, Rock CL, Stefanick ML.
    Menopause; 2006 May 01; 13(3):423-33. PubMed ID: 16735939
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E, Canfell K.
    Am J Epidemiol; 2009 Jul 01; 170(1):24-8. PubMed ID: 19468078
    [Abstract] [Full Text] [Related]

  • 20. Vasomotor symptoms usually reappear after cessation of postmenopausal hormone therapy: a Swedish population-based study.
    Lindh-Astrand L, Brynhildsen J, Hoffman M, Hammar M.
    Menopause; 2009 Jul 01; 16(6):1213-7. PubMed ID: 19455070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.